3-(2-(6-(tert-Butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutanone hydrochloride
97%
- Product Code: 44226
CAS:
1628338-77-1
| Molecular Weight: | 306.8300 g./mol | Molecular Formula: | C₁₇H₂₃ClN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a cyclobutanone ring and a benzimidazole moiety, makes it valuable for developing compounds with potential therapeutic applications. It is often explored in the design of inhibitors targeting specific enzymes or receptors, particularly in the context of anti-inflammatory, anticancer, or antiviral drug development. The tert-butyl group enhances the compound's stability and bioavailability, which is crucial for optimizing drug candidates. Researchers also leverage its unique scaffold to study structure-activity relationships (SAR) and improve the efficacy and selectivity of new pharmaceutical agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿5,607.00 |
+
-
|
3-(2-(6-(tert-Butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutanone hydrochloride
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a cyclobutanone ring and a benzimidazole moiety, makes it valuable for developing compounds with potential therapeutic applications. It is often explored in the design of inhibitors targeting specific enzymes or receptors, particularly in the context of anti-inflammatory, anticancer, or antiviral drug development. The tert-butyl group enhances the compound's stability and bioavailability, which is crucial for optimizing drug candidates. Researchers also leverage its unique scaffold to study structure-activity relationships (SAR) and improve the efficacy and selectivity of new pharmaceutical agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :